Hosam Hamed1, Mohammed Said2, Hosam Elghadban2, Ahmed Elgeidie3. 1. Gastrointestinal Surgical Center, Mansoura University, Jehan street, Postal code, Mansoura, Dakahleyya, 35516, Egypt. Hosam-eldin@hotmail.com. 2. General Surgery Department, Mansoura University, Jehan street, Mansoura, Dakahleyya, Egypt. 3. Gastrointestinal Surgical Center, Mansoura University, Jehan street, Mansoura, Dakahleyya, Egypt.
Abstract
INTRODUCTION: Bariatric leakage (BL) is a serious complication with a variety in available treatment options. Endoscopic stenting is preferred because of its minimally invasive nature in morbidly obese patients. Various modifications have been applied to stents since its use in palliation of malignant strictures. Few studies have exclusively evaluated the efficacy of bariatric stents in management BL. METHODS: A retrospective cohort study of patients with BL managed by bariatric stents in the period between July 2014 and January 2019. The primary outcome was the clinical success in healing of leakage and secondary outcomes included adverse events (AEs), hospital stay and procedure-related mortality. RESULTS: Forty-five patients were included in this study. Clinical success occurred in 33 patients (73.3%). There was no stent-related mortality. The most frequent stent-related complications were reflux (62.2%), intolerance (55.6%), and migration (17.8%). Severe AEs occurred in 9 patients (20%). The overall complications rate was higher in diabetic patients (P = 0.048). Intolerance was significantly associated with shorter interval to management (P = 0.02). Stent migration was higher in male patients (P = 0.019) and higher BMI (P = 0.024). CONCLUSION: Endoscopic stenting is a double-edged weapon that must be handled cautiously. It is a highly effective therapy, and early intervention is the main determinant of its efficacy. But it is not a treatment without complications (80%). The variant and high prevalence of complications mandates a strict follow-up throughout the stenting duration.
INTRODUCTION: Bariatric leakage (BL) is a serious complication with a variety in available treatment options. Endoscopic stenting is preferred because of its minimally invasive nature in morbidly obesepatients. Various modifications have been applied to stents since its use in palliation of malignant strictures. Few studies have exclusively evaluated the efficacy of bariatric stents in management BL. METHODS: A retrospective cohort study of patients with BL managed by bariatric stents in the period between July 2014 and January 2019. The primary outcome was the clinical success in healing of leakage and secondary outcomes included adverse events (AEs), hospital stay and procedure-related mortality. RESULTS: Forty-five patients were included in this study. Clinical success occurred in 33 patients (73.3%). There was no stent-related mortality. The most frequent stent-related complications were reflux (62.2%), intolerance (55.6%), and migration (17.8%). Severe AEs occurred in 9 patients (20%). The overall complications rate was higher in diabeticpatients (P = 0.048). Intolerance was significantly associated with shorter interval to management (P = 0.02). Stent migration was higher in male patients (P = 0.019) and higher BMI (P = 0.024). CONCLUSION: Endoscopic stenting is a double-edged weapon that must be handled cautiously. It is a highly effective therapy, and early intervention is the main determinant of its efficacy. But it is not a treatment without complications (80%). The variant and high prevalence of complications mandates a strict follow-up throughout the stenting duration.
Authors: Peter B Cotton; Glenn M Eisen; Lars Aabakken; Todd H Baron; Matt M Hutter; Brian C Jacobson; Klaus Mergener; Albert Nemcek; Bret T Petersen; John L Petrini; Irving M Pike; Linda Rabeneck; Joseph Romagnuolo; John J Vargo Journal: Gastrointest Endosc Date: 2010-03 Impact factor: 9.427
Authors: Bart J M Leenders; Arnold Stronkhorst; Frans J Smulders; Grard A Nieuwenhuijzen; Lennard P L Gilissen Journal: Surg Endosc Date: 2013-02-23 Impact factor: 4.584
Authors: Diogo Turiani Hourneaux de Moura; Eduardo Guimarães Hourneaux de Moura; Manoel Galvão Neto; Pichamol Jirapinyo; Newton Teixeira; Ivan Orso; Luiz Gustavo Quadros; Artagnan Amorim; Filipe Medeiros; Durval Rosa Neto; João de Siqueira Neto; Alvaro Albano; Luiz Henrique de Sousa; Delano Almeida; Igor Antunes Marchetti; Flávio Ivano; João Henrique Felicio de Lima; Marcelo Falcão; Christopher C Thompson Journal: Surg Obes Relat Dis Date: 2019-05-22 Impact factor: 4.734
Authors: Alberto Baptista; Diogo Turiani Hourneaux De Moura; Pichamol Jirapinyo; Eduardo Guimarães Hourneaux De Moura; Andres Gelrud; Michel Kahaleh; Alberto Salinas; Luis Carlos Sabagh; Andrés Ospina; Víctor Zambrano Rincones; Raul Doval; Jack William Bandel; Christopher C Thompson Journal: Gastrointest Endosc Date: 2018-12-06 Impact factor: 9.427
Authors: Carlos Serra; Aniceto Baltasar; Luis Andreo; Nieves Pérez; Rafael Bou; Marcelo Bengochea; Juan José Chisbert Journal: Obes Surg Date: 2007-07 Impact factor: 4.129